Very excited that our work has just been published in Nature Medicine! nature.com/articles/s4159… A multimodal study reporting one-year cognitive, serum biomarker, and structural neuroimaging findings in 351 patients hospitalised with COVID-19🧠🦠📰 @gkwood Professor Benedict D Michael MBChB, FRCP, PhD 1/9

Congratulations to Professor Geoffrey E. Hinton Geoffrey Hinton, the founding director of Gatsby Computational Neuroscience Unit UCL Faculty of Life Sciences, who has today been awarded the #NobelPrize in Physics for his pioneering work enabling machine learning ucl.ac.uk/news/2024/oct/…

What was encephalitis lethargica and what might have caused it? Have a look at our #OpenAccess paper in @BrainComms to see our new findings: doi.org/10.1093/brainc…. A 🧵with the highlights... (1/11)

Autoimmune encephalitis

After 2 years living in the UK, finally preparing for #PLAB1 #IMG 📖💉💊

Interesting article by Jonathan Rogers

A patient with acute cognitive disturbance, characterized by agraphia, acalculia, left right disorientation, and digital agnosia. The so-called Gertsmann syndrome. Any comments on this MRI? Does it contribute to the explanation of the cognitive disorder? What about etiology?

Psychiatric Comorbidities in Persons With #Epilepsy Compared With Persons Without Epilepsy. A Systematic Review and Meta-Analysis What can we learn from this study? 1/3 🧠⚡🧑‍⚕️ jamanetwork.com/journals/jaman…

Aprovechando el mes de hacer consciencia de epilepsia, les comparto este póster que resume los principales fármacos anticrisis e información útil de ellos en la práctica diaria. Fue realizado en conjunto con nuestros residentes en especial la Dra. Pilar Robles Instituto Nacional de Neurología y Neurocirugía 🧠🧠⚡️

Check out our latest report of a potential new early #cerebralamyloidangiopathy related #inflammation neuroimaging biomarker: sulcal hyperintensity UCLH UCL Queen Square Institute of Neurology Neurology Journal - which could allow earlier diagnosis...but more research is needed! Open Access doi.org/10.1212/WNL.00…

Everything is changing in neurology. Everywhere. All the time. The landscape of dementia has been particularly dynamic, in ways that matter to patients, families, and clinicians So why did we create this issue on Dementia, just 2 years after our last one?

An outstanding #Encephalitis2024 conference. Congrats to Encephalitis International on such a significant and inspiring event. Picture with a fantastic team. My mentors from UCL, Oxford and KCL: @michael_zandi, Prof. Angela Vincent, and Tom Pollak. Thank you!

Suggested Evaluation of a Patient With a Positive Antinuclear Antibody Test: #MedEd #MedX #MedTwitter #RheumTwitter #rheumatology Dr Ihab Suliman Dr. Akhil 🇮🇳

The optimal amount of exercise to improve cognitive function. 🧵1/10

Medicine and #psychiatry in this country changed significantly today. Let’s hope this shift doesn’t come at the cost of quality #palliative care, or lead to premature, unnecessary deaths among the vulnerable, poor, and mentally ill. Time for the Lords to earn its keep…

Important study & big step forward for treatment-resistant #depression. 48wk RCT, #pramipexole showed ~4-point QIDS-SR benefit over placebo. Less hype, but bigger effects than psychedelic trials, for a scalable option that’s available to clinicians now. thelancet.com/journals/lanps…

I think this is the most exciting thing to happen in depression for research for at least the last decade. Pramipexole works for TRD.

Happy to share that I’ve passed #PLAB1 2/3 ✅ one more to get my GMC registration (medical license to practice)! #IMG #UK

Jajajaja

Medical graduates who have passed #PLAB2 which courses/ resources did you use and which ones do you recommend? Thanks!